LIVE
Cohance Lifesciences Limited engages in the contract research, development, and manufacturing of new chemical entity (NCE) based intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs in India, the United States, Europe, and internationally. The company offers small molecule APIs, advanced intermediates, and starting materials; antibody drug conjugates; high-purity oligonucleotide building blocks comprising phosphoramidites, nucleosides, pseudouridine, NTPs, CAP reagents, GalNAc conjugates, and fluorescent dyes; pellets and finished dosage forms; and. Track COHANCE LIFESCIENCES LTD's live NSE:COHANCE share price ₹426.80 (+0.36%), market cap ₹₹163B, P/E 91.2. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for COHANCE — real-time NSE India stock intelligence.
Open
₹425.05
High
₹436.70
Low
₹424.00
Prev. Close
₹425.25
52W High
₹1,038.90
52W Low
₹266.70
Cohance Lifesciences Limited engages in the contract research, development, and manufacturing of new chemical entity (NCE) based intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs in India, the United States, Europe, and internationally. The company offers small molecule APIs, advanced intermediates, and starting materials; antibody drug conjugates; high-purity oligonucleotide building blocks comprising phosphoramidites, nucleosides, pseudouridine, NTPs, CAP reagents, GalNAc conjugates, and fluorescent dyes; pellets and finished dosage forms; and
Key Takeaway
COHANCE LIFESCIENCES LTD is rated none with a P/E of 91.2x — understand the valuation context before sizing a position.
★ Recommended
Ask AI: Is COHANCE LIFESCIENCES LTD fairly valued right now?
Because a P/E of 91.2x needs to be compared against sector peers and growth expectations to be meaningful.
Continue Research
View events affecting COHANCE LIFESCIENCES LTD
Because the investment case must account for macro and company-specific developments — events reveal the 'why' behind price moves.
Trace sector ripple effects
Because Healthcare moves create upstream and downstream implications that affect the entire thesis.
Intelligence Path
Growth
Govt Exposure
Policy Dependence
Execution Quality
News Sensitivity
Debt Strength
619 Cr
Revenue
20 Cr
Net Profit
3.8%
ROE
0%
ROCE
4.68
EPS
| ₹ in Crore | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|
| Revenue | 1,331 | 1,034 | 2,608 | 2,269 | 2,269 |
| Net Profit | 411 | 300 | 487 | 179 | 180 |
| ROE (%) | — | — | — | 3.8% | 3.8% |
| EPS (₹) | — | — | — | 4.68 | 4.68 |
| Debt/Equity | — | — | — | 9.9 | 9.9 |